PRINCETON, NJ--(Marketwire - October 30, 2007) - Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company that develops and markets dermatology products, today announced its financial results for the third quarter ended September 30, 2007. Total revenues increased to $7.5 million for the third quarter of 2007 from $4.1 million in the second quarter of 2007, and represent 83% sequential growth. Revenue growth is due primarily to increased U.S. revenues from Vusion® Ointment and Xolegel® Gel.
